1 – 10 of 83
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
- Mitigation of pretreatment-derived inhibitors during lignocellulosic ethanol fermentation using spent grain as a nitrogen source
- 2018
- Immune tolerance induction : What have we learned over time?
-
Monosaccharide Derivatives with Low-Nanomolar Lectin Affinity and High Selectivity Based on Combined Fluorine-Amide, Phenyl-Arginine, Sulfur-π, and Halogen Bond Interactions
Zetterberg, Fredrik R. ; Peterson, Kristoffer LU ; Johnsson, Richard E. LU ; Brimert, Thomas ; Håkansson, Maria LU ; Logan, Derek T. LU
; Leffler, Hakon
LU
and Nilsson, Ulf J.
LU
(2018)
In ChemMedChem
13(2).
p.133-137
Mark
- The role of the laboratory in diagnosis and management of inhibitory antibodies in haemophilia
- How I manage patients with inherited haemophilia A and B and factor inhibitors
-
Haemophilia B : Where are we now and what does the future hold?
Dolan, Gerry ; Benson, Gary ; Duffy, Anne ; Hermans, Cedric ; Jiménez-Yuste, Victor ; Lambert, Thierry ; Ljung, Rolf LU
; Morfini, Massimo
and Zupančić Šalek, Silva
(2018)
In Blood Reviews
32(1).
p.52-60
Mark
- 2017
- Galectin Inhibitors – Molecular Tools in Biomedical Research and Clinical Implications
-
Outcome measures for adult and pediatric hemophilia patients with inhibitors
Hermans, Cedric ; Auerswald, Günter ; Benson, Gary ; Dolan, Gerry ; Duffy, Anne ; Jiménez-Yuste, Victor ; Ljung, Rolf LU
; Morfini, Massimo
; Lambert, Thierry
and Osooli, Mehdi
LU
, et al.
(2017)
In European Journal of Haematology
99(2).
p.103-111
Mark
- Monomer-dependent secondary nucleation in amyloid formation
- 2016
- Current view and outcome of ITI therapy : A change over time?